Guardant Health, Inc. (GH) Financial Statements
Industry: Medical Laboratories (Services)
In fiscal 2025, Guardant Health reported revenue of $982.0M, up 32.9% from $739.0M the year before. Net income was -$416.3M (a -42.4% net margin), or -$3.32 per diluted share. Gross margin was 64.5% and operating margin was -44.5%. Operating activities generated -$184.8M of cash, leaving -$233.1M of free cash flow. At fiscal year end, Guardant Health held $2.01B in total assets against $2.11B in total liabilities, including $378.2M of cash and equivalents.
Open the full interactive Guardant Health financials → Quarterly statements, key ratios, valuation history and price charts.
Guardant Health Key Stats
| Share Price | $162.09 |
|---|---|
| Market Cap | $21.54B |
| Revenue YoY Growth | +32.9% |
| 52-Week Range | $61.73 – $187.22 |
| Shares Outstanding | 132.9 million (basic, 2026 Q2) |
Guardant Health Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $286.7M | $373.7M | $449.5M | $563.9M | $739.0M | $982.0M |
| Cost of Goods Sold | $541.7M | $784.7M | $993.9M | $1.13B | $1.18B | $349.0M |
| Gross Profit | -$254.9M | -$411.0M | -$544.4M | -$564.7M | -$443.6M | $633.0M |
| Operating Income | -$254.9M | -$411.0M | -$544.4M | -$564.7M | -$443.6M | -$437.2M |
| Pre-Tax Income | -$245.9M | -$384.5M | -$653.4M | -$478.8M | -$435.1M | -$417.5M |
| Income Tax | $379,000 | $300,000 | $1.1M | $685,000 | $1.3M | -$1.3M |
| Net Income | -$246.3M | -$384.8M | -$654.6M | -$479.4M | -$436.4M | -$416.3M |
| Diluted EPS | -$2.60 | -$4.00 | -$6.41 | -$4.28 | -$3.56 | -$3.32 |
Guardant Health Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $265.2M | $281.3M | $301.7M | $335.0M |
| Net Income | -$92.7M | -$128.5M | -$112.1M | -$120.1M |
| Diluted EPS | -$0.74 | -$1.02 | -$0.85 | -$0.90 |
Guardant Health Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $833.0M | $492.2M | $141.6M | $1.13B | $525.5M | $378.2M |
| Current Assets | $1.89B | $1.11B | $1.19B | $1.35B | $1.06B | $1.47B |
| Total Assets | $2.27B | $2.20B | $1.61B | $1.79B | $1.49B | $2.01B |
| Current Liabilities | $66.8M | $194.7M | $193.2M | $205.9M | $225.6M | $302.7M |
| Total Long-Term Debt | $806.3M | $1.13B | $1.14B | $1.14B | $1.14B | $1.50B |
| Total Liabilities | $916.2M | $1.56B | $1.55B | $1.63B | $1.63B | $2.11B |
| Shareholders' Equity | $1.30B | $645.0M | $60.2M | $158.7M | -$139.6M | -$99.3M |
Guardant Health Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$103.9M | -$209.0M | -$309.5M | -$325.0M | -$239.9M | -$184.8M |
| Cash From Investing | -$617.1M | -$63.2M | $149.8M | $840.2M | -$261.3M | -$627.2M |
| Cash From Financing | $1.41B | -$66.8M | -$189.1M | $477.4M | -$996,000 | $671.1M |
| Free Cash Flow | -$140.1M | -$284.1M | -$386.9M | -$345.5M | -$274.9M | -$233.1M |
Figures from Guardant Health's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Guardant Health financials page for every line item.
Guardant Health Company Profile
| Ticker | GH |
|---|---|
| Exchange | Nasdaq |
| Industry | Medical Laboratories (Services) |
| Headquarters | Palo Alto, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001576280 |
Frequently Asked Questions
What was Guardant Health's revenue in fiscal 2025?
Guardant Health (GH) reported revenue of $982.0M for fiscal 2025.
What is Guardant Health's annual revenue history?
Guardant Health's annual revenue by fiscal year: 2020: $286.7M; 2021: $373.7M; 2022: $449.5M; 2023: $563.9M; 2024: $739.0M; 2025: $982.0M.
What was Guardant Health's net income in fiscal 2025?
Guardant Health reported net income of -$416.3M for fiscal 2025.
What was Guardant Health's earnings per share (EPS) in fiscal 2025?
Guardant Health's diluted EPS was -$3.32 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Guardant Health generate in fiscal 2025?
Guardant Health generated -$233.1M of free cash flow in fiscal 2025.
What was Guardant Health's revenue last quarter?
In its most recent reported quarter (2026 Q2), Guardant Health reported revenue of $335.0M.
How much debt does Guardant Health have?
Guardant Health reported $1.50B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Guardant Health are outstanding?
Guardant Health reported a weighted average of 132.9 million basic shares outstanding in 2026 Q2.
What is Guardant Health's market cap?
Based on its latest closing price, Guardant Health (GH) has a market capitalization of about $21.54B.
When does Guardant Health's fiscal year end?
Guardant Health's fiscal year end, as registered with the SEC, is December 31.
Where is Guardant Health headquartered?
Guardant Health lists its business address in Palo Alto, California in its SEC filings.